innovation for industry
News | Health ＆ life sciences
According to a study conducted by the Institute for Health and Medical Research (Inserm), 1.6% of the population suffers from chronic fibromyalgia pain, which can considerably alter the quality of life. By combining medical research and advanced micro-nanotechnologies, the startup Remedee Labs has designed the first endorphin stimulator for individual use, with the aim of providing an answer to patients' chronic pain.
Remedee Labs offers a safe, effective and affordable endorphin stimulation solution. The latter, approved by clinical trials since 2018, provides a solution for various therapeutic applications. "This wristband will enable the precise delivery of a painkiller for pathologies that have no effective treatment, such as fibromyalgia, migraine or even osteoarthritis," says Jacques Husser, founder of Remedee Labs.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.